Patient Recruitment/Retention White Papers & Case Studies
-
Increasing Patient Participation In Clinical Trials: Six Areas Of Focus From Patients And Advocates
2/14/2020
Meaningful collaboration between patients, sites, and sponsors can yield improved clinical trial outcomes. As part of that important collaboration, we see that effective patient input has the potential to increase patient participation rates in clinical trials. Incorporating patient insights into clinical trial design and execution is the first step.
-
The Most Important Voice Is Missing: The Case For Including Patient Insights In Protocol Design
2/14/2020
Patient voice isn’t an accessory; it’s foundational. Patients are key to clinical trials, and relegating them to mere “subjects” diminishes their value. Including the patient voice in study design and development can make an enormous difference in recruitment, enrollment, and retention. Doing so also pleases regulators, who are increasingly putting a premium on patient-focused drug development. It doesn’t have to be difficult, but getting it wrong--or not doing it at all--can undermine a trial.
-
Clinical Trial Transparency Policy Reference Guide
1/14/2020
A transparency policy must clearly define the following commitments related to disclosure, transparency and data sharing: protocol registration, results disclosure, clinical study report (CSR) synopses, full CSRs, plain-language summaries (PLS) and individual patient-level data (IPD). Access this guide, which provides a complete overview.
-
Returning Study Results To Research Participants
10/16/2019
Studies show that most clinical trial participants want to know what was learned from their involvement. A growing number of sponsors are implementing plans to deliver plain language summaries to trial participants. Read this white paper to learn about the current best practices for the content and preparation of plain language summaries, and the current guidance for how sponsors should work with Institutional Review Boards (IRBs) which have oversight of the clinical trials for which the summaries are provided.
-
Clinical Trials And Travel Tribulations: Overcoming Logistical And Financial Challenges For Improved Access And Outcomes
9/19/2019
In this paper, dive into the logistical and financial challenges which increasingly impact all clinical trial stakeholders - from patients and sites, to sponsors and contract research organizations (CROs).
-
UBC Pathways
9/3/2019
UBC PathwaysTM can help your patients stay on therapy…even when UBC is not your patient support provider
-
AstraZeneca Takes An Innovative Approach To Trial Results Summaries
8/28/2019
AstraZeneca made a commitment in 2015 to deliver PLS in advance of the European Medicines Agency (EMA) policy coming into play, says Julie Holtzople, Clinical Trial Transparency Operations Director. Many other sponsors have followed suit, taking a proactive approach to clinical trial disclosure and transparency. The statistics explain why. According to a 2017 (CISCRP) study1, 72% of the respondents said they want a summary of their results, 91% thought receiving results was really important, and 53% said they had never received a summary of results. “Our leadership made that commitment, and then we had to go figure out how to do it,” Holtzople says.
-
Addressing The New Imperative To Include Females In Clinical Trials
8/27/2019
As a leader in women’s health research, Health Decisions has extensive experience in recruitment of female subjects for trials in a variety of indications, including but not limited to women-specific indications. Health Decisions is pleased to share some lessons from our experience in women’s health studies to assist sponsors in increasing female participation in studies across the therapeutic spectrum.
-
Rideshare Integration
8/15/2019
The only solution that offers both ride and reimbursement automation within one portal.
-
Midlantic Urology Associates Introduces Added Convenience For Patients With Rideshare Program
7/15/2019
Midlantic Urology Associates had been employing a single driver for all participant pick-ups. This proved to be inefficient and unsustainable, so they began utilizing taxis. This alternative was costly and unreliable – there had to be a better way. ClinCard’s integration with Lyft has not only improved the experience for patients and study coordinators but has also helped with recruitment as new patients are enrolling in the study as a result of this added convenience.